Hydropothecary, Soon HEXO, Uplists to TSX

The Hydropothecary Corporation Announces Graduation to the TSX, Shareholder Meeting for Rebranding to HEXO

GATINEAU, Quebec, June 21, 2018 (GLOBE NEWSWIRE) — The Hydropothecary Corporation (“THCX” or the “Company”) (TSX-V:THCX) announced today that it has received approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange (the “TSX-V”) and list its common shares and common share purchase warrants expiring January 30, 2020 on the TSX. The common shares and warrants will commence trading on the TSX effective Friday, June 22, 2018, at which time the Company will also “ring the bell” to open the TSX. In conjunction with listing on TSX, the common shares and warrants will be voluntarily delisted from the TSX-V effective upon commencement of trading on the TSX.

Graduating to a major exchange such as the TSX demonstrates Hydropothecary’s growth and proven ability to execute. Since 2013, our company has demonstrated our continuous commitment to providing industry-leading, innovative products while never compromising the quality or consistency that we are known for. We are thrilled to represent this on the TSX.

Sebastien St-Louis, Hydropothecary’s Chief Executive Officer and co-founder

The common shares and warrants will trade under the symbols “HEXO” and “HEXO.WT” respectively. The Company has previously announced the launch of HEXO as its new brand for the adult-use cannabis market, while continuing to use the Hydropothecary brand for the medical cannabis market.

In addition, further to the Company’s launch of the HEXO brand, the Company wishes to announce that it intends to change its corporate name from The Hydropothecary Corporation to HEXO Corp. In connection with the name change, the Company will call a special meeting of its shareholders to seek shareholder approval for the change of its corporate name. The Company intends to complete the corporate name change as soon as practicable following receipt of shareholder approval and any requisite regulatory approvals.

The Company also announces that in connection with its listing on the TSX, it has provided notice to terminate its market-making agreement with MJM Markets and Consulting.

About The Hydropothecary Corporation

The Hydropothecary Corporation creates and distributes innovative, award-winning, easy to use, and easy to understand products under Health Canada’s Access to Cannabis for Medical Purposes Regulations. One of the country’s lowest-cost producers, Hydropothecary is rapidly increasing its production capacity in the lead-up to adult-use cannabis. Hydropothecary will supply the adult-use cannabis markets in Canada and elsewhere under its newly launched HEXO brand and will continue to serve medical cannabis clients under the original Hydropothecary brand.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter